SAC Capital
SAC is a multi-strategy, private asset management firm founded by Steven A. Cohen. He founded SAC in 1992 with 9 employees and $25 million in assets under management. As of September 2007, the firm had grown to over 800 employees with approximately $14 billion in assets under management.
SAC's initial investment style was "trading" oriented. However, the firm has evolved into a multi-strategy, multi-disciplinary, investment management firm emphasizing rigorous research and risk management practices.
SAC's investment strategies include, but are not limited to: Fundamental and Technical Long/Short Equity Portfolios, Global Quantitative Strategies, Fixed Income and Credit, Global Macro Strategies, Convertible Bonds, and Emerging Markets.
View Older Stories View More Recent Stories
-
Cohen's SAC Capital Boosts Stake in United Therapeutics (UTHR) to 7.4%
-
Cohen's SAC Capital Discloses 3% Stake in James River Coal (JRCC)
-
Cohen's SAC Capital Accumulates Stakes in Target (TGT), Pilgrim's Pride (PPC) and Some Financials (STI, FITB, STT)
-
Cohen's SAC Capital Cuts Stake in Invitrogen (IVGN) to 5.3%
-
Ron Insana To Close Up Shop And Head To SAC Capital
-
Cohen's SAC Capital Boosts Stake in Incyte (INCY) to 6.4%
-
Cohen's SAC Capital Raises Stake in Invitrogen (IVGN) from 5.2% to 6.9%
-
Cohen's SAC Capital Cuts Stake in Barrier Therapeutics (BTRX) to 1.21%
-
Who's Talk Was Louder on Lehman (LEH) Today - Bill Gross or Ben Bernanke?
-
SAC Capital Still Trading With Lehman (LEH) - Bloomberg
-
Cohen's SAC Capital Discloses 8% Stake in Barrier Therapeutics (BTRX), Files 13D
-
Cohen's SAC Capital Accumulates 5.1% Stake in Inspire Pharmaceuticals (ISPH)
-
Cohen's SAC Capital Boosts Stake in Akorn (AKRX) to 5.6%
-
Cohen's SAC Capital Discloses 5.2% Stake in Invitrogen (IVGN), Supports Merger With Applera
-
Cohen's SAC Capital Discloses 5% Stake in Navistar (NAV)
-
UPDATE: Cohen's SAC Capital Accumulates 5.3% Stake In Takeover Target Take-Two Interactive (TTWO)
-
Cohen's SAC Capital Files 13D On Take-Two Interactive (TTWO) Showing 5.3% Stake
-
Cohen's SAC Capital Builds 6.1% Stake in Emergency Medical Services (EMS)
-
Cohen's SAC Capital Accumulates 7.1% Stake in Sanderson Farms (SAFM)
-
Cohen's SAC Capital Discloses 7.6% Stake in Pilgrims Pride (PPC)
-
Buy Orient-Express (OEH) on Potential Takeover Target -Barron's
-
Cohen's SAC Capital Boosts Stake in Fresh Del Monte (FDP) to 5.1%.
-
Cohen's SAC Capital Accumulates 6.8% Stake in Cardiome Pharma (CRME)
-
D. E. Shaw Boosts "Active" Stake in Orient-Express Hotels (OEH) to 7.6%
-
Cohen's SAC Capital Discloses Nearly 5% Stake in Willbros Group (WG)
-
Cohen's SAC Capital Boosts Stake in Stewart Enterprises (STEI) to Nearly 6%
-
Has The Fear Factor Made Ethanol Stocks A Bargain? (PEIX, AVR, VSE, GPRE)
-
What's Steven Cohen's SAC Capital Buying? A Few Banks Among Other Things (BK, C)
-
Cohen's SAC Capital Discloses 5.5% Stake in Orient-Express Hotels (OEH), Express Concerns About Share Structure
-
Cohen's S.A.C. Capital Discloses 6.3% Stake in Barrier Therapeutics (BTRX)
-
Cohen's SAC Capital Boosts Stake in Chiquita Brands (CQB) to 5.4%
-
Cohen's SAC Capital Disclosese 4.6% Stake in Auto Parts Maker Tenneco (TEN)
-
Cohen's SAC Capital Accumulates 6.3% Stake in Hasbro (HAS)
-
Cohen's SAC Capital Builds 5% Stake in Jean Maker True Religion (TRLG)
-
Cohen's SAC Capital Lowers Stake in Assisted Living Concepts (ALC) to 4.2%
-
Cohen's SAC Discloses 5.1% Stake in Applied Bio (ABI); Wants Celera Seperated, CEO Gone and All Options Explored
-
Cohen's SAC Capital Accumulates 7.6% Stake in PF Chang's (PFCB)
-
HealthCor Discloses 5.6% Stake in Affymax (AFFY)
-
Corel (CREL) Receives Offer from Majority Shareholder for $11; SAC Capital's Steve Cohen Hired to Special Committee for Responding to Proposal
-
Cohen's SAC Capital Discloses 5% Stake in Auxilium Pharmaceuticals (AUXL)
-
Following Steven Cohen: Century Aluminum (CENX) May Be Headed to $75
-
Cohen's SAC Capital Discloses 4.1% Stake in Xenoport (XNPT)
-
Cohen's SAC Capital Moves Out of Pharmion (PHRM)
-
Following Dan Loeb: Mylan (MYL) - A Cheap Drug To Own
-
Cohen's SAC Capital Wants A Higher Bid for Pharmion (PHRM)
-
Cohen's SAC Capital Accumulates 8.3% Stake in Orexigen Therapeutics (OREX)
-
Cohen's SAC Capital Discloses 5.1% Stake in Albermarle (ALB)
-
Cohen's SAC Capital Discloses 8.9% Stake in Assured Guaranty Ltd. (AGO)
-
Cohen's SAC Capital Discloses 7.7% Stake in Takeover Target VistaCare (VSTA)
-
Cohen's SAC Capital Boosts Stake in Pharmion (PHRM) to 8.3%
